A J Bridges|A K Ho - JoVE Visualize

Showing results (181-190 of 201) with videos related to

Pageof 21

Sort By:

Preparative Biochemistry|January 1, 1986

A simple purification of calmodulin by reversed phase chromatography with hydrophobic polymer 3520A K Ho, Q L Ling, K J Shang, et al.

Journal of Medicinal Chemistry|January 5, 1996

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorA J Bridges, H Zhou, D R Cody, et al.

Journal of Medicinal Chemistry|April 26, 1996

Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A M Thompson, et al.

Journal of Neurochemistry|September 1, 1996

Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cellsC L Chik, T Inukai, T Ogiwara, et al.

British Journal of Pharmacology|February 1, 1981

Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamusJ Arendt, A K Ho, C Laud, et al.

Endocrinology|July 14, 2007

Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytesA K Ho, D M Price, W G Dukewich, et al.

Journal of Medicinal Chemistry|February 16, 1996

Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A J Bridges, et al.

Journal of Medicinal Chemistry|March 1, 1991

Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationshipJ M Domagala, A J Bridges, T P Culbertson, et al.

Endocrinology|December 23, 2006

Histone H3 phosphorylation in the rat pineal gland: adrenergic regulation and diurnal variationC L Chik, T G Arnason, W G Dukewich, et al.

Journal of Medicinal Chemistry|January 24, 1992

New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic riskJ P Sanchez, A J Bridges, R Bucsh, et al.

Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:

Pageof 21

Preparative Biochemistry|January 1, 1986

A simple purification of calmodulin by reversed phase chromatography with hydrophobic polymer 3520A K Ho, Q L Ling, K J Shang, et al.

Journal of Medicinal Chemistry|January 5, 1996

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptorA J Bridges, H Zhou, D R Cody, et al.

Journal of Medicinal Chemistry|April 26, 1996

Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A M Thompson, et al.

Journal of Neurochemistry|September 1, 1996

Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cellsC L Chik, T Inukai, T Ogiwara, et al.

British Journal of Pharmacology|February 1, 1981

Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamusJ Arendt, A K Ho, C Laud, et al.

Endocrinology|July 14, 2007

Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytesA K Ho, D M Price, W G Dukewich, et al.

Journal of Medicinal Chemistry|February 16, 1996

Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A J Bridges, et al.

Journal of Medicinal Chemistry|March 1, 1991

Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationshipJ M Domagala, A J Bridges, T P Culbertson, et al.

Endocrinology|December 23, 2006

Histone H3 phosphorylation in the rat pineal gland: adrenergic regulation and diurnal variationC L Chik, T G Arnason, W G Dukewich, et al.

Journal of Medicinal Chemistry|January 24, 1992

New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic riskJ P Sanchez, A J Bridges, R Bucsh, et al.

Pageof 21